Emodin CAS: 518-82-1

CAS NO: 518-82-1
Emodin
Chemical Name: Emodin
Molecular Formula: C15H10O5
Formula Weight: 270.24
CAS No.: 518-82-1
Description Review
Description

Emodin is a natural anthraquinone compound found in various plants, including rhubarb and buckthorn. It has been studied for its potential health benefits, including anti-inflammatory, anti-cancer, anti-diabetic, and anti-viral properties. Emodin's CAS number is 518-82-1, with the chemical name of 1,3,8-Trihydroxy-6-methylanthraquinone. The molecular formula of Emodin is C15H10O5, and its molecular weight is 270.24 g/mol.

Top Ten Keywords and Synonyms:

  1. Anti-Inflammatory
  2. Anti-Cancer
  3. Anti-Diabetic
  4. Anti-Viral
  5. Natural Anthraquinone
  6. NF-κB Inhibition
  7. Apoptosis Inducer
  8. Wound Healing
  9. Immune Modulatory
  10. AMPK Activation

Synonyms:

  1. 6-Methyl-1,3,8-trihydroxyanthraquinone
  2. Frangula emodin
  3. Rheum emodin
  4. Archin
  5. Floxuridine
  6. NSC-281272
  7. Pagorutin

Health Benefits of Emodin:

  1. Anti-Inflammatory Properties: Emodin has been shown to have potent anti-inflammatory properties due to its ability to inhibit the activity of various inflammatory signaling pathways, including NF-κB.

  2. Anti-Cancer Properties: Emodin has been found to exhibit anti-cancer properties by inhibiting cell growth and inducing apoptosis in cancer cells.

  3. Anti-Diabetic Effects: Emodin has been shown to improve glucose metabolism by activating AMP-activated protein kinase (AMPK), a key regulator of glucose uptake and insulin sensitivity.

  4. Anti-Viral Properties: Emodin has been found to exhibit antiviral activity against various viruses such as SARS-CoV-2, making it useful in the treatment of infectious diseases.

Potential Effects of Emodin:

  1. Wound Healing: Emodin has been shown to enhance wound healing by promoting the growth and differentiation of skin cells.

  2. Immune Modulation: Emodin may modulate immune function by enhancing the activity of white blood cells and promoting the production of cytokines.

  3. Cardiovascular Protection: Emodin has been found to protect against cardiovascular disease by inhibiting the activity of certain enzymes involved in lipid synthesis and improving endothelial function.

Product Mechanism:

Emodin works by modulating various cellular pathways involved in inflammation, cell growth, and survival. It has been shown to inhibit the activity of various enzymes involved in the growth and proliferation of cancer cells and induce apoptosis, ultimately leading to cell death. Emodin also exhibits antiviral activity by inhibiting viral replication and attachment to host cells. Additionally, it has been found to improve glucose metabolism by activating AMPK, a key regulator of glucose uptake and insulin sensitivity.

Safety:

Emodin is generally considered safe when consumed in food or supplement form. However, high doses may cause gastrointestinal upset, including diarrhea and nausea. It is important to consult with a healthcare provider before use, especially if taking medications or if pregnant or breastfeeding.

Side Effects:

The most common side effects of Emodin include gastrointestinal upset, including diarrhea and nausea. Rare but severe adverse events such as liver toxicity and kidney damage have also been reported.

Dosing Information:

The optimal dosage of Emodin has not been established, and it varies depending on the intended use. As a dietary supplement, Emodin is typically taken in doses ranging from 50 mg to 500 mg per day.

Conclusion:

Emodin is a natural anthraquinone compound found in various plants that offers numerous potential health benefits, including anti-inflammatory, anti-cancer, anti-diabetic, and anti-viral properties. It is generally considered safe when consumed in food or supplement form, but caution should be exercised when taking it alongside certain medications. Further research is needed to determine the optimal dosage and effectiveness of Emodin for various health conditions. It holds great promise as a potential therapeutic agent for the management of various diseases and conditions.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code